Skip to content
Disclosery

13F-HR filed by ACUTA CAPITAL PARTNERS, LLC

ACUTA CAPITAL PARTNERS, LLC filed this 13F-HR for the quarter ended 2023-12-31, filed 2024-02-14, with 39 holding rows worth $177,652,122.

Accession
0001104659-24-023144
Filer
CIK 1582844
Filed
2024-02-14
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q4 2023

A holdings report, 39 entries on the cover page, a total value of $177,652,122 stated on the cover page (in dollars after the unit check, H1), rows summing to $177,652,122 with VALUE read as dollars as filed, 13F file number 028-16527. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
RAYZEBIO INC75525N107COM378,069$23,504,550dollars as filed
CYMABAY THERAPEUTICS INC23257D103COM492,155$11,624,701dollars as filed
ROCKET PHARMACEUTICALS INC77313F106COM366,015$10,969,470dollars as filed
KURA ONCOLOGY INC COM50127T109Stock701,349$10,085,399dollars as filed
EYEPOINT INC COM NEW30233G209Stock425,128$9,824,708dollars as filed
VAXCYTE INC COM92243G108Stock117,373$7,371,024dollars as filed
SAREPTA THERAPEUTICS INC803607100COM70,600$6,807,958dollars as filed
PRAXIS PRECISION MEDICINES I74006W207COM NEW299,636$6,675,890dollars as filed
DISC MEDICINE INC COM254604101Stock115,500$6,671,280dollars as filed
TAYSHA GENE THERAPIES INC877619106COMMON STOCK3,589,333$6,353,119dollars as filed
VIRIDIAN THERAPEUTICS INC92790C104COM281,500$6,131,070dollars as filed
Tourmaline Bio Inc89157D105Common Stock231,882$6,070,671dollars as filed
OCULAR THERAPEUTIX INC67576A100COM1,310,000$5,842,600dollars as filed
Mersana Therapeutics Inc59045L106Common Stock2,368,000$5,493,760dollars as filed
HILLEVAX INC43157M102COM324,600$5,209,830dollars as filed
IMMUNOVANT INC45258J102COM119,489$5,034,072dollars as filed
REVOLUTION MEDICINES INC COM76155X100Stock160,000$4,588,800dollars as filed
APELLIS PHARMACEUTICALS INC03753U106COM76,100$4,555,346dollars as filed
ARCELLX INC COMMON STOCK03940C100Stock77,000$4,273,500dollars as filed
WHITEHAWK THERAPEUTICS INC00032Q104CMN1,849,402$3,735,792dollars as filed
TERNS PHARMACEUTICALS INC COM880881107Stock555,260$3,603,637dollars as filed
CRINETICS PHARMACEUTICALS INC COM22663K107Stock87,500$3,113,250dollars as filed
CELLDEX THERAPEUTICS INC NEW15117B202COM NEW69,400$2,752,404dollars as filed
AN2 THERAPEUTICS INC037326105COM132,000$2,704,680dollars as filed
DYNE THERAPEUTICS INC COM26818M108Stock147,836$1,966,219dollars as filed
VERASTEM INC92337C203COMMON STOCK232,249$1,890,507dollars as filed
Applied Therapeutics Inc03828A101Common Stock525,100$1,759,085dollars as filed
ENLIVEN THERAPEUTICS INC COM29337E102Stock123,876$1,714,444dollars as filed
4D MOLECULAR THERAPEUTICS INC COM35104E100Stock74,500$1,509,370dollars as filed
CYPHERPUNK TECHNOLOGIES INC52187K200COM NEW354,166$1,468,018dollars as filed
CELLECTAR BIOSCIENCES INC15117F807COM477,500$1,322,675dollars as filed
INSMED INC COM PAR $.01457669307Stock29,500$914,205dollars as filed
ARGENX SE SPONSORED ADR04016X101ADR2,400$913,032dollars as filed
VERONA PHARMA PLC925050106SPONSORED ADS19,000$377,720dollars as filed
SPRINGWORKS THERAPEUTICS INC85205L107COM10,000$365,000dollars as filed
CENTESSA PHARMACEUTICALS PLC152309100SPONSORED ADS38,138$303,578dollars as filed
TYRA BIOSCIENCES INC90240B106COMMON STOCK8,867$122,808dollars as filed
ANAVEX LIFE SCIENCES CORP032797300COM NEW1,000$22,500dollars as filedput
NUVATION BIO INC67080N119WARR90,832$5,450dollars as filed

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001104659-24-023144this filing2024-02-14acceptance time not in the bulk data set